Public COA audit

Tesamorelin

Audited September 5, 2026

Consistent with a legitimate COA

Document structure and test panels align with what we expect from authentic lab reports.

Legitimacy
92
Confidence
93%
Panels
5/7
Purity (printed)
99.9%

Scored high because document structure and panels look consistent with authentic lab output and broad panel coverage (5/7).

Document details

Fields extracted from the certificate — not order or payment data.

Batch / lot
TESA10-0528
Identity method
MALDI-MS
Sample date
2026-06-01
Issue date
2026-06-17

Original certificate

Embedded copy of the stored COA PDF or image. Download it for your records — PeptIQ’s audit is separate from the lab document itself.

Loading original certificate…

7-panel checklist

Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.

5 of 7 present · 5 passed · 0 failed · 0 reported · 2 missing

Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.

  • Identity

    Tested · passed · core

    Compound identity confirmed (e.g. HPLC, mass spec).

    Tesamorelin confirmed

  • Purity

    Tested · passed · core

    Reported purity percentage for the analyte.

    99.9%

  • Heavy metals

    Tested · passed

    Lead, arsenic, cadmium, mercury, or similar limits.

    <0.01ppm

  • Microbial

    Not on this certificate file

    Bioburden / microbial limits testing.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Endotoxin

    Tested · passed · core

    LAL or chromogenic endotoxin assay.

    <0.05 EU/mL

  • Sterility

    Tested · passed

    Sterility testing where applicable.

    Not Detected

  • Residual solvent / water

    Not on this certificate file

    Residual solvents or water content limits.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

How to read this

Had data · good

Panel present with a pass (or clear acceptance).

Had data · bad

Panel present with a fail — a concrete quality signal.

Had data · unclear

Value reported without an explicit pass/fail mark.

Missing on this file

Not on this certificate file. Lowers file thoroughness; a sibling endotoxin/purity report for the same lot may still exist. PeptIQ’s score still factors coverage.

Findings

Evidence-linked observations from this audit.

  • High purity confirmed

    99.9% purity by RP-HPLC with clean chromatogram showing single major peak at 9.722 min retention time

  • Identity confirmed

    MALDI-MS shows [M+H]+ at 5136.657, consistent with Tesamorelin (expected MW 5135.9 g/mol)

  • Comprehensive testing

    Document includes identity, purity, content quantitation (10.66 mg), sterility, heavy metals, and endotoxin panels

  • Lot number present

    Lot TESA10-0528 clearly stated

  • Dates reasonable

    Sample received June 1, 2026; COA issued June 17, 2026 (16-day turnaround)

  • Lab identification

    Bioviridian with verification URL and QR code provided; signed by Shane Straight, M.S., Principal Chemist

  • Professional presentation

    Well-formatted document with clear tables, chromatograms, mass spectrum, and vendor branding (American Peptides)

PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.